Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Clementi

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|October 1, 1979
Phenytoin cumulation kineticsJ P Allen, T M Ludden, S R Burrow, et al.
Clinical Pharmacy|August 1, 1987
Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrationsP J Godley, T M Ludden, W A Clementi, et al.
Chirality|January 1, 1994
Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin)W A Clementi, T Q Garvey, G D Clifton, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Experience with intrainstitutional clinical evaluations of newly marketed preparations as a basis for drug-product selection to hospital formulariesJ A Green, W A Clementi, M G Bufton, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1982
Endogenous generation of hydralazine from labile hydralazine hydrazonesW A Clementi, J L McNay, T Talseth, et al.
Journal of Chromatography|January 4, 1980
Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazineK D Haegele, H B Skrdlant, T Talseth, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1979
Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazoneT Talseth, K D Haegele, J L McNay, et al.
Therapeutic Drug Monitoring|January 1, 1988
Clinical assessment of a two-compartment Bayesian forecasting method for lidocaineC L Beach, J A Farringer, C C Peck, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1984
Chronic acetazolamide intoxicationW A Watson, J C Garrelts, P D Zinn, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|October 1, 1979
Phenytoin cumulation kineticsJ P Allen, T M Ludden, S R Burrow, et al.
Clinical Pharmacy|August 1, 1987
Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrationsP J Godley, T M Ludden, W A Clementi, et al.
Chirality|January 1, 1994
Single dose pharmacokinetics of (S)-atenolol administered orally as a single enantiomer formulation and as a racemic mixture (Tenormin)W A Clementi, T Q Garvey, G D Clifton, et al.
Drug Intelligence & Clinical Pharmacy|January 1, 1986
Experience with intrainstitutional clinical evaluations of newly marketed preparations as a basis for drug-product selection to hospital formulariesJ A Green, W A Clementi, M G Bufton, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1982
Endogenous generation of hydralazine from labile hydralazine hydrazonesW A Clementi, J L McNay, T Talseth, et al.
Journal of Chromatography|January 4, 1980
Quantitative analysis of hydralazine pyruvic acid hydrazone, the major plasma metabolite of hydralazineK D Haegele, H B Skrdlant, T Talseth, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1979
Pharmacokinetics and cardiovascular effects in rabbits of a major hydralazine metabolite, the hydralazine pyruvic-acid hydrazoneT Talseth, K D Haegele, J L McNay, et al.
Therapeutic Drug Monitoring|January 1, 1988
Clinical assessment of a two-compartment Bayesian forecasting method for lidocaineC L Beach, J A Farringer, C C Peck, et al.
Journal of Toxicology. Clinical Toxicology|January 1, 1984
Chronic acetazolamide intoxicationW A Watson, J C Garrelts, P D Zinn, et al.
Journal of Pharmaceutical Sciences|September 1, 1988
Absolute bioavailability and dose proportionality of betaxolol in normal healthy subjectsT M Ludden, D A Boyle, D Gieseker, et al.
Pageof 3